One year of nuclear cardiology in Europe by Olivier Lairez & Denis Agostini
REVIEW ARTICLE
One year of nuclear cardiology in Europe
Olivier Lairez1,2 • Denis Agostini3,4
Received: 7 July 2016 / Accepted: 8 July 2016 / Published online: 16 September 2016





CAD Coronary artery disease
CRT Cardiac resynchronization therapy
CZT Cadmium zinc telluride
ED-B Extra-domain B of fibronectin
MPI Myocardial perfusion imaging
SPECT Single-photon emission computed tomography
Preamble
Since the introduction of the need to use imaging for the
monitoring of cardiomyopathies and particularly ischemic
cardiomyopathies in international guidelines, articles
reporting the place, the accuracy and the prognostic impact
of cardiac imaging have grown exponentially. During
2015, the European Journal of Nuclear Medicine and
Molecular Imaging published selected pre-clinical, tech-
nical and clinical studies sweeping the most advanced
items in nuclear cardiology. Advances in nuclear cardiol-
ogy led the Journal to publish revision from the European
Association of Nuclear Medicine guidelines for radionu-
clide myocardial perfusion imaging (MPI) [1]. The current
review provides a summary of selected articles represen-
tative of the most interesting advances in the field of
nuclear medicine published in the Journal during 2015.
Development of hardwares and impact
on practices for myocardial perfusion imaging
Context
Last years had seen growing interest in reducing acquisition
times for MPI. This dynamics has led to the development of
new hardware capable of acquiring MPI studies in a fraction
of the time usually required by conventional tools, with the
same image quality and diagnosis accuracy. The two most
significant advances in this field were represented by the
development of cadmium zinc telluride (CZT) crystals and
multifocal collimation by IQ-SPECT. CZT crystals had
opened the door for dynamic SPECT leading to the exciting
perspectives of myocardial blood flow and coronary reserve
quantification in a daily practice. Meanwhile, IQ-SPECT,
without allowing the same perspectives for dynamic
SPECT, can reduce acquisition times leading to improve
patient throughput, facilitate the workload of department of
nuclear medicine and, by extension, reduce radiation
exposure. IQ-SPECT, which can be applied as a plug-in on
general-purpose cameras, is a good compromise for centers
with general activity that do not want to make the invest-
ment of dedicated cardiac camera.
Considering the emergence of these new cameras, the
article of Caobelli et al. drew our attention by reporting the
feasibility of one-eighth time gated myocardial perfusion
SPECT using IQ-SPECT in clinical practice [2].
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Method and results
Caobelli and co-authors [2] hypothesized that images
obtained by acquisition times one-eighth of standard times
would be statistically equivalent to the standard protocol.
They compared global and regional perfusion defects,
images quality scores, left ventricular volumes and func-
tion obtained from set of images acquired at 6 s/view and
12 s/view in 50 patients. They found a significant decrease
in image quality with the 6 s/view compared with the 12 s/
view. But all images were rated as adequate and the dif-
ference was considered as clinically negligible. They did
not find difference between set of images for perfusion
scores, leading to a similar image-based diagnosis of global
and regional coronary artery disease (CAD). A similar
pattern was observed for semi-quantitative analysis using
summed scores. Left ventricular volumes were higher in
images obtained with the shorter acquisition time than with
the longer acquisition time, but left ventricular ejection
fraction did not significantly differ between the two
acquisition times. This study supported the use of a shorter
acquisition time in clinical practice (from 20 to 2.5 min),
and by extension, patient radiation exposure reduction
using IQ-SPECT for MPI.
The use of hybrid cameras for attenuation
correction
Context
Like PET few years ago, and because specificity of MPI
cans be limited by attenuation artifacts, nowadays, most of
constructor offer to correct attenuation using computed
X-ray tomography to acquire linear attenuation coefficient
maps. However, several reports on the use of attenuation
correction in MPI have shown discordant results and its
utility in routine clinical practice is still debated. Until
now, analysis of wall thickening using ECG gating has
been routinely used to identify attenuation artifacts. Con-
sidering these two different approaches, Benkiran et al.
offer to evaluate the consequences of computed X-ray
tomography-based attenuation correction and wall thick-
ening analysis on the diagnostic performance of MPI in
routine clinical settings [3].
Method and results
Benkiran and co-authors [3] explored prospectively, in 70
patients, the relative impact of computed tomography-based
attenuation correction and the segmental thickening scores
using ECG-gating on the sensitivity, specificity, and overall
accuracy on the basis of coronary angiography (for 19 % of
patients) and ECG, echocardiography, and clinical follow-
up (for 81 % of patients). In their population, the prevalence
of ischemic heart disease was low with 81 % of patients
considered free of CAD; and 3, 11, and 4 % of patients with
myocardial ischemia, myocardial necrosis, and both ische-
mia and necrosis, respectively. The sensitivity, specificity,
and overall accuracy were, respectively, 77, 60, and 63 %
for ‘standard’ SPECT analysis (without attenuation cor-
rection or wall thickening analysis); 67, 81, and 79 % for
computed tomography-based attenuation correction analy-
sis; and 69, 98, and 93 % for segmental thickening-based
analysis. Differences were statistically significant for
specificity and overall accuracy by taking ‘standard’
SPECT analysis as reference. Interestingly, segmental
thickening-based analysis led to 33 and 1 % of right and
wrong change, respectively, in the final interpretation,
whereas CT-based attenuation correction analysis led to 24
and 13 % of right and wrong change, respectively, in the
final interpretation. The additional effective dose for com-
puted tomography-based attenuation correction was 2 mSv.
Although that both computed tomography-based attenua-
tion correction analysis and segmental thickening-based
analysis led to improved specificity and diagnostic accuracy
compared with ‘standard’ SPECT analysis, all these results
led the authors to consider gated SPECT as a self-sufficient
modality for CAD screening and follow-up; and to consider
attenuation correction only when doubt remains after gated
SPECT analysis.
Looking beyond myocardial perfusion
Context
Because balanced multivessel disease can result in falsely
normal myocardial perfusion imaging study, new tools are
needed to increase the accuracy of SPECT for the assess-
ment of CAD.
As highlight in the editorial of Ben-Haim and Agostini
[4], CZT crystals provide improved sensitivity (eight to ten
times better than conventional SPECT), spatial resolution
and energy resolution. These improvements, in addition to
allowing dynamic SPECT with kinetic analysis of
myocardial tracer uptake, provide incremental diagnostic
information over perfusion data alone. Myocardial ische-
mia results, generally, in sequential alterations in
myocardial diastolic, then systolic functions followed by
electrographic and symptomatic manifestations. Based on
the capacity of CZT cameras to better study myocardial
behavior, Gimelli et al. evaluated the interplay between
myocardial ischemic burden and post-stress left ventricular
diastolic and systolic abnormalities in patients with sus-
pected or known CAD [5].
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On the other hand, the emergence of hybrid scanners
combining SPECT and CT, allowing combination of
functional and morphological approach, opens new per-
spectives for coronary imaging. Because high coronary
artery calcium score is associated with a greater degree of
stenosis and ischemia, combination of coronary artery
calcium score and myocardial perfusion assessment could
allow detecting falsely normal myocardial perfusion
SPECT in patients with balanced multivessel disease.
Yuoness et al. explored the incidence of severe CAD in
stable symptomatic patients with normal myocardial per-
fusion imaging and high coronary artery calcium score [6].
Method and results
Gimelli and co-authors explored the relationships among
CAD severity and extent, regional myocardial ischemia
and early post-stress left ventricular functional perfor-
mance in 471 consecutive patients with angina-like chest
pain and known or suspected CAD referred for CZT
myocardial perfusion scintigraphy [5]. They found that the
magnitude of post-stress left ventricular systolic dysfunc-
tion paralleled the increase in coronary artery extent,
whereas the occurrence of a significant stress-induced
systolic dysfunction was limited to patients with multi-
vessel disease. Finally, summed difference score and
stress-to-rest peak filling rate ratio were independent pre-
dictors of significant CAD surpassing the effects of mea-
sures of stress-induced volumetric overload and systolic
impairment. Experimental studies have suggested that
stress-induced left ventricular diastolic stunning is an ear-
lier and more durable manifestation of ischemia than sys-
tolic stunning [7]. This study shows how myocardial
perfusion imaging by CZT scintigraphy, allowing early
assessment of stress-induced left ventricular abnormalities,
offers the opportunity to combine the evaluation of
myocardial perfusion with left ventricular diastolic and
systolic functions, to better cover the ‘‘ischemic cascade’’.
For their part, Yuoness and co-authors explored 26
consecutive symptomatic patients without known CAD
with normal perfusion myocardial SPECT (even for left
ventricular systolic function) and a coronary artery calcium
score of [1,000 [6]. All patients underwent invasive
coronary angiography, which found 58 % of severe CAD.
Among patients with severe CAD, 60 % had three-vessel
disease, 47 % required percutaneous coronary intervention
and 54 % underwent coronary artery bypass grafting. This
study opens a door for hybrid scanners in the evaluation of
coronary artery atherosclerosis associating functional
assessment by myocardial perfusion imaging and mor-
phological assessment by coronary artery calcium score to
overcome false-negative studies in patients with multives-
sel disease.
Integrating exercise tolerance to better assess
prognosis
Context
SPECT myocardial perfusion imaging is routinely used
for risk assessment in patients with known or suspected
CAD. It provides additional prognostic information on
clinical data, coronary anatomy and exercise stress score.
Marini et al. evaluated the prognostic value of combining
imaging-derived indexes of ischemia and exercise toler-
ance [8].
Method and results
Marini and co-authors combined imaging indexes of
ischemia severity with maximal achieved workload and
maximal rate pressure product in 1,502 patients with rest
and exercise gated SPECT myocardial perfusion imaging
[8]. Clinical prognostic index was defined by summed
difference score divided by maximal rate pressure pro-
duct*105. Among the 357 patients with reversible perfu-
sion defects, after multivariate analysis, summed difference
score showed a weak predictive value for major adverse
cardiac events. Normalization of ischemic threshold
improved summed difference score risk stratification and
clinical prognostic index correctly predicted the incidence
of major adverse cardiac events both in univariate and
multivariate analysis. This study confirms that normalizing
imaging score of ischemia severity and extension by clin-
ical indexes of exercise tolerance improves risk stratifica-
tion for major cardiac events. These results supported the
integration of the clinical evaluation of ischemic threshold
as an easily applicable tool in the interpretation of SPECT
myocardial perfusion imaging.
Can nuclear cardiology help to predict response
to cardiac resynchronization therapy?
Context
Conventional criteria for selection of patients for cardiac
resynchronization therapy (CRT) lead to about one-third of
no significant benefits [9]. Although mechanical cardiac
dyssynchrony has been recognized as an essential criterion
for response to CRT, conventional imaging tests for
dyssynchrony have not yet been shown to be of value in
selecting patients for CRT. This had led several authors to
question the value of nuclear cardiology imaging to assess
the left ventricular dyssynchrony and predict CRT
response.
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Method and results
Mukherjee and co-authors evaluated prospectively gated
myocardial perfusion SPECT in the prediction of response
to CRT in 32 non-ischemic dilated cardiomyopathy
patients [10]. First-harmonic fast Fourier transform was
used to extract a phase array from MPI at baseline and
3 months after CRT implantation. They showed that
responders had significantly larger phase standard devia-
tion and phase histogram bandwidth compared with non-
responders, based on NYHA functional class improvement
and increase in left ventricular ejection fraction by more
than 5 % on follow-up. Receiver operating characteristic
curve analysis demonstrated 86 % sensitivity and 80 %
specificity at a cutoff value of 43 for phase standard
deviation; and 86 % sensitivity and 80 % specificity at a
cutoff value of 128 for phase histogram bandwidth in the
prediction of response to CRT.
For their part, Chen and co-authors evaluated prospec-
tively equilibrium radionuclide angiography in the predic-
tion of response to CRT in 24 heart failure patients (79 %
ischemic and 21 % idiopathic) [11]. Left ventricular phase
shift and left ventricular phase standard deviation were
obtained on the phase image and used to predict response to
CRT based on a reduction of at least 15 % in left ventricular
end-systolic volume 48 h after CRT implantation. Baseline
left ventricular phase shift and left ventricular phase stan-
dard deviation were larger in responders. Responders
demonstrated a significant reduction of left ventricular phase
shift and left ventricular phase standard deviation 48 h after
CRT implantation. Receiver operating characteristic curve
analysis demonstrated 80 % sensitivity and 89 % specificity
at a cutoff value of 25 % for left ventricular phase shift; and
87 % sensitivity and 89 % specificity at a cutoff value of
8.5 % for left ventricular phase standard deviation in the
prediction of response to CRT.
All these results suggest that left ventricular phase
analysis derived from both myocardial perfusion SPECT
and equilibrium radionuclide angiography could be useful
for prediction of acute and late response to CRT.
The new era of PET/MRI in clinical practice
Context
The recent emergence of hybrid PET/MRI has opened new
perspectives for cardiovascular applications. PET and MRI
provide additional and complementary information.
Numerous recent studies suggest promising applications in
the cardiovascular field [12]. As such, the article of Nappi
et al. is a good example of the potential of hybrid scanners
in clinical practice [13].
Method and results
Nappi and co-authors investigated the potential role of
PET/MR imaging in the assessment of cardiac involvement
in 13 patients with Anderson–Fabry disease without car-
diac symptoms [13]. They performed coregistration of
myocardial 18F-FDG uptake by PET and MR images
including cine-MRI, T1- and T2-weighted, and late
gadolinium enhancement images. They found 38 % of left
ventricular hypertrophy and focal late gadolinium
enhancement. Among these patients, 60 % had positive
T2-weighted images and focal FDG uptake in the corre-
sponding myocardial territory. The 40 % remaining
patients had negative T2-weighted images but heteroge-
neous FDG uptake (assessed by measure of the coefficient
of variation of the uptake of the 17 segments). All these
patients had elevated cardiac troponin values. Among the
patients without left ventricular hypertrophy or late
gadolinium enhancement, 29 % had heterogeneous
myocardial FDG uptake. These patients were hemizygous
for the mutation and started enzyme replacement therapy
long time ago. This study illustrates the capacity of new
hybrid scanners integrating PET and MRI to bring mor-
phological, functional and tissue information for the
assessment of pro-inflammatory and fibrotic myocardial
diseases.
The emergence of molecular imaging
Context
Numerous metabolic factors can impact cardiovascular
prognosis. One of the most striking examples is the impact
of chronic kidney on cardiovascular prognosis. Kidney
disease induces activation of growth factors, proto-onco-
genes, plasma norepinephrine, cytokines, and angiotensin
II. These factors regulate intracellular processes that
accelerate cardiac hypertrophy, myocardial fibrosis, and
apoptosis [14]. The common point of all these pathologic
processes is the impairment in myocardial fatty acid
metabolism. This impaired metabolism can now be
explored by imaging, and the new perspectives brought by
the recent works of Nishimura et al. [15] drew our
attention.
Method and results
Nishimura and co-authors explored myocardial fatty acid
metabolism by SPECT using the iodinated fatty acid
analogue, iodine-123-b-methyl iodo-phenyl-pentade-
canoic acid (BMIPP) on 155 hemodialysis patients
without CAD (based on the results of invasive coronary
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angiography) [15]. Tracer uptake of each segment was
visually graded and assigned an uptake score of 0
(normal), 1 (mildly reduced), 2 (moderately reduced), 3
(severely reduced), or 4 (none), and the BMIPP score
was calculated by summing the results of the 17
myocardial segments. Focal pattern of tracer uptake was
defined as BMIPP defect scores C2 in C2 consecutive
segments. Among the 155 included patients, 95 patients
had abnormal BMIPP SPECT findings (defined by
BMIPP score C6) and were enrolled in the study. Focal
pattern in BMIPP SPECT was found in 44 % of patients.
After a follow-up of 5 ± 2 years, cardiac deaths were
higher in the focal (71 %) than in the non-focal (23 %,
P\0.001) group. After multivariate analysis, BMIPP
summed score and focal pattern were independent risk
factors for cardiac with hazard ratios of 8.7 and 2.3,
respectively. Among patients with focal pattern, 48 %
showed focally reduced uptake of BMIPP in the single
coronary artery area. The predictive potential for coro-
nary territorial BMIPP scores for cardiac deaths was
higher in the left anterior descending artery area. These
findings show that severe impairment in BMIPP SPECT
and focally impaired myocardial fatty acid imaging in
the left anterior descending artery area are strong risk
factors for cardiac death in hemodialysis patients. Over
the results applied to hemodialysis patients, the study
illustrates to potential of BMIPP SPECT to explore
myocardial metabolism and opens the door of molecular
imaging in the field of cardiac imaging.
Identifying critical molecular mechanisms
of atherosclerotic disease to develop novel
therapeutic strategies
Context
High-risk atherosclerotic plaque represents the suscepti-
bility of a plaque to rupture, and its detection has become
the goal of new imaging techniques. The morphological
approach does not provide information regarding func-
tional variables, such as plaque metabolism and inflam-
mation, which are recognized markers of vulnerability.
Molecular imaging techniques can quantify specific bio-
logical processes, thus giving insight into the functional
parameters of tissues [16]. The extra-domain B (ED-B) of
fibronectin was found recently to be expressed in advanced
atherosclerotic plaques. This led Dietrich et al. to test
whether ED-B antibody conjugated with 99 m-technetium
(99mTc) would be suitable for in vivo visualization of
atherosclerotic plaque lesions in atherosclerotic western-
fed diet Apo-E-/- mice [17].
Method and results
Seven Apo-E-/- mice fed with high-cholesterol diet were
imaged with high-resolution MRI 24 h prior to 99mTc
labeled ED-B antibody SPECT imaging and compared
with 5 wild-type mice fed on normal chow used as control.
In vivo 99mTc-labeled ED-B antibody SPECT imaging of
the high-fat diet Apo E-/- mice demonstrated a signifi-
cant higher signal activity than controls in the thoracic
area, which co-localized with aortic arch and the supra-
aortic arteries. The specificity of this increased signal
activity was confirmed by ex vivo autoradiography. By
histology, high-fat diet Apo E-/- mice expressed high-
risk atherosclerotic plaques with inflammatory processes
characterized by infiltrating macrophages and lymphocytes
as compared with controls. There was a significant corre-
lation between the size of aortic plaque areas identified by
99mTc-labeled ED-B antibody autoradiography and the
macrophage-infiltrated plaque areas by histology. These
promising results illustrate the potential of molecular
imaging, and particularly of nuclear imaging, in the field of
vulnerable plaque identification.
Conclusion
Nuclear cardiology in Europe during 2015 was represen-
tative of the evolutionary turning point that knows the
nuclear cardiology: the development of faster cameras,
which change our daily practice and open the way for
dynamic SPECT, the surpassing of myocardial perfusion,
which improve myocardial assessment and prognosis, the
emergence of hybrid imaging, that change our way of
understanding the disease and the perspective for new
tracers, which opens the way of molecular imaging. All
these points bring exciting perspectives for the next years.
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